Literature DB >> 19268974

Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.

Magdalena Targosz-Gajniak1, Joanna Siuda, Stanisław Ochudło, Grzegorz Opala.   

Abstract

BACKGROUND: Brain images of patients with Alzheimer's disease (AD) on magnetic resonance imaging (MRI) show white matter lesions (WML), which are attributed to degenerative changes of small vessels. These lesions are supposed to be among the factors supporting the diagnosis of probable AD; however their correlation with the severity of dementia requires further studies.
METHODS: We examined four groups of patients with cognitive impairment: Ten patients with amnestic-MCI (Mild Cognitive Impairment), 11 with mild AD (21-24 points in MMSE), 17 with moderate AD (11-20 points in MMSE) and 15 with severe AD (3-10 points in MMSE). The T2 and FLAIR MRI sequences of the brain of each patient were assessed using the White Matter Lesions Semiquantitive Rating Scale, taking into consideration the amount, size and distribution of WML.
RESULTS: WML of the brain were seen in almost all patients with AD and MCI on T2 and FLAIR sequences. The positive correlation between the patients' age and the amount and size of WML, in subcortical (T2: p<0.01, r=0.39; FLAIR: p<0.05, r=0.31) and in the periventricular region (T2: p<0.05, r=0.28; FLAIR: p<0.05, r=0.35) has been shown on both sequences. There was no correlation between the size or distribution of lesions and either hypertension or homocysteine blood level. The analysis revealed also that in both sequences, the severity of lesions in the periventricular region increased with the progression of the disease (T2: p=0.038; FLAIR: p=0.02).
CONCLUSIONS: A significant factor correlating with the location of WML in patients with MCI and AD is the age of patient. The amount and size of WML in the periventricular and subcortical regions of the brain correlates with the severity of dementia. Hypertension and hyperhomocysteinemia have no influence on the presence of described lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268974     DOI: 10.1016/j.jns.2009.02.314

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

1.  Retrospective identification and characterization of mild cognitive impairment from a prospective population cohort.

Authors:  Karen Ritchie; Marie-Laure Ancelin; Ephrem Beaino; Florence Portet; Adam M Brickman; Jean-François Dartigues; Christophe Tzourio; Anne-Marie Dupuy; Craig W Ritchie; Claudine Berr; Sylvaine Artero
Journal:  Am J Geriatr Psychiatry       Date:  2010-08       Impact factor: 4.105

2.  Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment.

Authors:  Janne M Papma; Marius de Groot; Inge de Koning; Francesco U Mattace-Raso; Aad van der Lugt; Meike W Vernooij; Wiro J Niessen; John C van Swieten; Peter J Koudstaal; Niels D Prins; Marion Smits
Journal:  Hum Brain Mapp       Date:  2013-09-23       Impact factor: 5.038

3.  [Neurodegenerative diseases].

Authors:  Wolfgang Reith
Journal:  Radiologe       Date:  2018-03       Impact factor: 0.635

4.  Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease.

Authors:  Quan Zhang; Randall B Stafford; Ze Wang; Steven E Arnold; David A Wolk; John A Detre
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Homocysteine and Mild Cognitive Impairment: Are These the Tools for Early Intervention in the Dementia Spectrum?

Authors:  Z Ansari
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

6.  Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion.

Authors:  Jian Huang; Jun Yang; Xingju Zou; Shilun Zuo; Jing Wang; Jing Cheng; Hao Zhu; Weiwang Li; Ming Shi; Gang Zhao; Zhirong Liu
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-08

7.  Age-related white matter changes.

Authors:  Yun Yun Xiong; Vincent Mok
Journal:  J Aging Res       Date:  2011-08-23

8.  Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease.

Authors:  Kenichi Oishi; Kazi Akhter; Michelle Mielke; Can Ceritoglu; Jiangyang Zhang; Hangyi Jiang; Xin Li; Laurent Younes; Michael I Miller; Peter C M van Zijl; Marilyn Albert; Constantine G Lyketsos; Susumu Mori
Journal:  Front Neurol       Date:  2011-08-24       Impact factor: 4.003

9.  Tau pathology and parietal white matter lesions have independent but synergistic effects on early development of Alzheimer's disease.

Authors:  Joakim Hertze; Sebastian Palmqvist; Lennart Minthon; Oskar Hansson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-04-19

Review 10.  Cerebral small vessel disease and Alzheimer's disease.

Authors:  Zhiyou Cai; Chuanling Wang; Wenbo He; Hanjun Tu; Zhengang Tang; Ming Xiao; Liang-Jun Yan
Journal:  Clin Interv Aging       Date:  2015-10-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.